A5101614062- Pharmaceutical Practices and Patient Outcomes
- Patient Safety and Medication Errors
- Antibiotic Use and Resistance
- Electronic Health Records Systems
- Post-Communist Economic and Political Transition
- Immunodeficiency and Autoimmune Disorders
- Agricultural economics and policies
- Health Systems, Economic Evaluations, Quality of Life
- Schizophrenia research and treatment
- Agricultural Economics and Policy
- Problem and Project Based Learning
- Blood Pressure and Hypertension Studies
- Medication Adherence and Compliance
- Noise Effects and Management
- RNA regulation and disease
- Cancer Immunotherapy and Biomarkers
- Online and Blended Learning
- Nosocomial Infections in ICU
- Statistical Methods in Clinical Trials
- Data Quality and Management
- Atrial Fibrillation Management and Outcomes
- Evaluation of Teaching Practices
- Functional Brain Connectivity Studies
- Antimicrobial Resistance in Staphylococcus
- Pharmaceutical studies and practices
Lifespan
2021-2022
Rhode Island Hospital
2012-2022
Providence College
2014-2021
Cooper Medical School of Rowan University
2019
University Hospitals of Cleveland
2018
Case Western Reserve University
2018
University School
2018
Rowan University
2017
The Royal Melbourne Hospital
2016
D'Youville College
2015
The high-value pharmacy enterprise (HVPE) framework and constituent best practice consensus statements are presented, the methods used to develop framework's 8 domains described. A panel of leaders an evidence- expert opinion-based approach define core aspirational elements that should be established within contemporary health-system enterprises by calendar year 2025. Eight HVPE were identified: Patient Care Services; Business Ambulatory Specialty Pharmacy Inpatient Operations; Safety...
Journal Article Achieving blood pressure control among renal transplant recipients by integrating electronic health technology and clinical pharmacy services Get access Daniel R. Migliozzi, Pharm.D., BCPS, BCPS Clinical Pharmacy Specialist Renal Transplant, Department of Pharmacy, Rhode Island Hospital, Providence Search for other works this author on: Oxford Academic Google Scholar Andrew Zullo, Pharm.D. doctoral student Health Services, Policy Practice, Brown University School Public...
Marked increases in exposure of some substrates have been noted poor metabolizers given inhibitors nonpolymorphic enzymes. Among the small number clinical trials conducted to investigate this problem, a wide variation degree maximum ratios (area under curve presence inhibitor/area extensive metabolizers) among different has reported, with reporting profound (> tenfold), and others demonstrating less remarkable changes (< twofold). The conduct such raises safety concerns for trial...
Oral Abstracts O1 Functionally distinct HMGB1 isoforms correlate with physiological processes in drug-induced SJS/TEN Daniel F. Carr, Wen-Hung Chung, Rosalind E. Jenkiins, Mas Chaponda, Gospel Nwikue, Elena M. Cornejo Castro, J. Antoine, Munir Pirmohamed O2 Hypersensitivity reactions to beta-lactams, does the t cell recognition pattern influence clinical picture? Natascha Wuillemin, Dolores Dina, Klara K. Eriksson, Yerly O3 Specific binding characteristics of HLA alleles associated...
Pharmacists are well positioned to provide transitions of care (TOC) services patients with heart failure (HF); however, hospitalizations for HF likely exceed the capacity a TOC pharmacist. We developed and validated tool help pharmacists efficiently identify high-risk maximize their potential impact by intervening on at highest risk 30-day all-cause readmission. conducted retrospective cohort study including adults admitted health system between October 1, 2016, 31, 2019. randomly divided...
Background: The timing and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia in trauma patients are not well characterized. This information is critical the selection of appropriate empiric antibiotics. objective this study was to determine incidence MRSA early-onset late-onset identify trauma-burn intensive care unit (ICU). Patients Methods: We conducted a retrospective cohort from January 2012 March 2015 burn ICU with clinical microbiologic evidence pneumonia....
Journal Article Initiative to improve thromboprophylactic enoxaparin exposure in hospitalized patients with renal impairment Get access Khaled A. Elsaid, Pharm.D., PhD, BCPS, BCPS Assistant Professor of Pharmaceutical Sciences Department Sciences, Massachusetts College Pharmacy and Health Boston, Clinical Pharmacist Specialist, Pharmacy, Rhode Island Hospital, Providence, RI Address correspondence Dr. Elsaid at the 179 Longwood Avenue, MA 02115-5896 (khaled.elsaid@mcphs.edu). Search for...
A multidisciplinary approach is recommended for the management of type 2 diabetes mellitus (DM). To evaluate impact a pharmacist intervention on haemoglobin A1c (HbA1c), systolic blood pressure (SBP), diastolic (DBP), and diabetes-related hospitalisations in an underserved cohort with unmanaged DM. This analysis was retrospective study. Criteria inclusion were persons DM defined as HbA1c values ≥8% at time enrolment, ≥18 years old, enrolment pharmacist-managed clinic ≥12 months. Pre-...
Health care institutions have recognized the importance of an effective antimicrobial stewardship program to optimize treatment outcomes, reduce costs, and resistance.1,2 It is that a successful should multifaceted interventions including but not limited formulary management, prior approval, dosage de-escalation optimization, restrictions achieve desired clinical economic outcomes. Clinical decision-support systems (CDSSs) been used successfully improve adverse-event rates, duration...
Opportunities exist to meaningfully reduce suboptimal prescription opioid use among older adults. Deprescribing is one possible approach reducing use. Appropriate interventions should outline how carefully taper opioids, closely monitor adverse events, substitute viable alternative and affordable nonopioid pain treatments, initiate medications for disorder properly manage disorders, as needed. We sought document understand provider perceptions begin developing effective safe deprescribing...